Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
STIMthis companyNeuronetics, Inc.	$2.12	-2.34×	4.07×	0.61×	-5.43×	-2342.1%	48.5%	-21.1%	-26.1%	-174.3%	-27.0%	-23.3%	4.04×	-2.07×	-3.74×	2.02×	0.0%	3	-3.35	2	C
CATXPerspective Therapeutics, Inc.	$0.82	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
CDXSCodexis, Inc.	$1.13	-3.26×	2.81×	2.02×	-4.86×	-459.7%	86.7%	-54.5%	-62.5%	-87.0%	-30.6%	-16.8%	1.45×	-0.66×	-7.96×	3.82×	0.0%	3	-6.21	1	D+
OABIOmniAb, Inc.	$5.32	-3.25×	0.79×	11.26×	-4.6×	-105.3%	-18.2%	-383.1%	-347.0%	-24.3%	-24.2%	-17.6%	0.08×	0.12×	0×	4.02×	0.0%	4	9.56	2	C
OSUROraSure Technologies, Inc.	$3.49	-2.57×	0.52×	1.55×	0.15×	-88.9%	41.9%	-59.2%	-59.8%	-20.2%	-18.6%	-0.0%	0.04×	3.28×	0×	6.58×	0.0%	4	3.11	2	B-
Peer median	—	-2.91×	0.88×	1.78×	-3.17×	-97.1%	21.0%	-56.8%	-61.1%	-37.0%	-27.4%	-17.2%	0.06×	0.19×	-3.98×	4.6×	0.0%	4	1.3	2	—